Aminophylline Injection

Aminophylline is used in emergency settings to provide rapid relief during acute asthma exacerbations, especially when inhaled beta-agonists (such as salbutamol) are not sufficient. It helps to dilate the bronchial airways and reduce airway inflammation, facilitating easier breathing and faster oxygen exchange.

For patients with COPD, including chronic bronchitis and emphysema, Aminophylline Injection aids in relieving persistent symptoms such as wheezing, breathlessness, and chronic cough. It improves airflow, thereby reducing respiratory distress and helping patients maintain better lung function during periods of acute exacerbation.

Aminophylline is effective in treating acute bronchospasms caused by allergic reactions, respiratory infections, or exposure to irritants (e.g., smoke or pollution). It acts quickly to open up constricted airways, alleviating symptoms such as shortness of breath, wheezing, and coughing.

In neonatal care, particularly for preterm infants, Aminophylline Injection is used to treat apnea of prematurity, a condition in which premature babies experience temporary cessation of breathing. Aminophylline stimulates respiratory drive, improving respiratory function and reducing the frequency and severity of apnea episodes in these vulnerable infants.

Aminophylline is used in the management of pulmonary edema secondary to heart failure. It helps to reduce the symptoms of respiratory distress by enhancing bronchial dilation and improving gas exchange in the lungs, providing critical support for patients with compromised cardiac and pulmonary function.

Aminophylline Injection may be employed in the management of respiratory failure, particularly in cases where other interventions (such as mechanical ventilation) are needed. It improves airflow, reduces the work of breathing, and increases the efficiency of oxygen transport in patients with conditions like acute respiratory distress syndrome (ARDS) or severe chronic obstructive pulmonary disease (COPD).